DEUTSCHE BANK AG\ - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$265,000
-4.7%
212,0000.0%0.00%
Q1 2022$278,000
-94.9%
212,000
-94.3%
0.00%
-100.0%
Q4 2021$5,419,000
-56.9%
3,700,000
-56.5%
0.00%
-66.7%
Q3 2021$12,570,000
+144.5%
8,500,000
+117.9%
0.01%
+200.0%
Q2 2021$5,141,000
+45.8%
3,900,000
+129.4%
0.00%0.0%
Q3 2020$3,525,000
-23.2%
1,700,000
-15.0%
0.00%
-33.3%
Q2 2020$4,590,000
+75.3%
2,000,000
+0.9%
0.00%
+50.0%
Q3 2019$2,618,000
-50.7%
1,982,000
-17.0%
0.00%
-33.3%
Q2 2019$5,313,000
+5.8%
2,387,000
-14.2%
0.00%0.0%
Q1 2019$5,021,0002,783,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$148,264,0002.95%
DeepCurrents Investment Group LLC 45,997,000$76,672,0002.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$64,158,0001.47%
WOLVERINE ASSET MANAGEMENT LLC 71,012,000$118,356,0001.28%
Opti Capital Management, LP 3,000,000$5,013,0000.46%
MIZUHO SECURITIES USA LLC 1,663,000$2,766,0000.38%
Verition Fund Management LLC 25,954,000$21,680,6590.24%
Aequim Alternative Investments LP 5,000,000$8,345,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 3,831,000$6,522,0000.18%
LORD, ABBETT & CO. LLC 23,424,000$39,095,0000.14%
View complete list of SAREPTA THERAPEUTICS INC shareholders